-
September 15, 2021 Interview with Doug Drysdale, CEO, Cybin IncDoug talks about the company’s mission to revolutionize mental healthcare, how Cybin is delivering powerful...
-
July 22, 2021 Cybin Receives Conditional Approval to Trade on NYSE AmericanAnd in other psychedelic stock news, Origin Therapeutics launches to make equity investments in emerging...
-
July 9, 2021 Psychedelic Business Spotlight: July 9, 2021This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance...
-
July 7, 2021 Psychedelic Biotech Company Cybin Partners with Greenbrook to Develop Innovative Depression TreatmentCybin CEO says agreement "serves as a major step toward establishing a national distribution network...
